Ketan Desai

Long/short equity, research analyst, biotech, healthcare
Ketan Desai
Long/short equity, research analyst, biotech, healthcare
Contributor since: 2008
Company: IMC
New Treatments For Osteoarthritis
Another Option Strategy For Vivus
India's Iran Gambit: The Hunt For Oil
Targacept Stumbles Again
One Way To Profit With Leveraged ETFs
When to Buy Biotechnology Stocks?
Earnings: What Happened to Dendreon?
Who Will Win the Hepatitis C Market?
What Now for Egypt?
India's Contradictory Economics
On Investment and Optimism
Myriad Genetics: I Told You So